

<!DOCTYPE html>
<html lang="uz-Cyrl-UZ">
<head>
   <!-- Global site tag (gtag.js) - Google Analytics -->
   <script async src="https://www.googletagmanager.com/gtag/js?id=UA-2682682-1"></script>
   <script>
      window.dataLayer = window.dataLayer || [];
      function gtag() { dataLayer.push(arguments); }
      gtag('js', new Date());
      gtag('config', 'UA-2682682-1');
   </script>
<title>
	
</title><meta charset="UTF-8" /><meta http-equiv="content-type" content="text/html; charset=UTF-8" /><meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=0.3, maximum-scale=3.0" /><link href="/css/mactform.css" rel="stylesheet" type="text/css" />
    <script src="/assets/js/jquery.min.js"></script>

    <style type="text/css">
        body, html {
            height: 100%
        }

        body {
            margin: 0;
            padding: 0;
            background-color: #fff;
            font-family: Ubuntu;
            font-family: Montserrat
        }

        /* .OFFICIAL_SOUR_TEXT, .PUBLICATION_ORIGIN {
            display: none;
        }*/

        .act_warning {
            color: red;
        }

        .night-mode {
            -webkit-filter: grayscale(100%) !important;
            filter: grayscale(100%) !important;
        }

        #divCont > div {
            /*overflow-y:  auto;*/
            overflow-x: auto;
            max-width: calc(100vw - 4px);
        }

        /*.TABLE_STD .BY_DEFAULT {
            overflow-y: auto;
            max-height: 80vh;
        }*/
    </style>
    <script>
        function toggle_night_mode() {
            $("body").toggleClass("night-mode")
        }
    </script>
</head>
<body>
    <a href="#" onclick="toggle_night_mode()" style="display: none;">toggle_night_mode</a>
    <div id="page">
        <table style="width: 100%; font-family: Arial; font-size: 14px; font-weight: bold;">
            <tr>
                <td style="width: 50%">
                    
                        <div class="act_warning">
                            Hujjat kuchini yo‘qotgan&nbsp;30.06.2020
                        </div>
                    
                    
                    
                </td>
                <td style="width: 50%" align="right">
                    
                    
                </td>
            </tr>
        </table>
        <div id="divBody" style="padding: 2px;">
            <div id="divCont" style="background:#ffffff;border:none;margin:auto;"><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><div name="onLBC-4367869" id="onLBC-4367869">[<b>OKOZ:</b><div id="LBC7382"><span class="iorRN">1.</span><span class="iorVal">14.00.00.00 Sogʻliqni saqlash. Jismoniy tarbiya. Sport. Turizm / 14.01.00.00 Sogʻliqni saqlash / 14.01.04.00 Sogʻliqni saqlash muassasalarini, aholini medikamentlar, dori-darmon vositalari va tibbiy buyumlar bilan taʼminlash. Dorixona]</span></div></div></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5988"></label><div name="onLS-4367869" id="onLS-4367869">[<b>TSZ:</b><div id="LS3700"><span class="iorRN">1.</span><span class="iorVal">Ijtimoiy-madaniy masalalar / Sogʻliqni saqlash. Sanitariyaga oid qonun hujjatlari]</span></div></div></div><div class="ACCEPTING_BODY"><div name="-4368086" id="-4368086">Oʻzbekiston Respublikasi sogʻliqni saqlash vazirining</div></div><div class="ACT_FORM"><div name="-4368087" id="-4368087">buyrugʻi</div></div><div class="ACT_TITLE"><div name="-4368088" id="-4368088">Kam uchraydigan kasalliklarni davolash uchun moʻljallangan Orfan dori vositalari roʻyxatini tasdiqlash toʻgʻrisida</div></div><div class="DEPARTMENTAL"><div name="-4368089" id="-4368089">[Oʻzbekiston Respublikasi Adliya vazirligi tomonidan 2019-yil 7-iyunda roʻyxatdan oʻtkazildi, roʻyxat raqami 3164]</div></div><div class="BY_DEFAULT"><div name="-4368091" id="-4368091"></div></div><div class="COMMENT"><label id="s527"></label><div class="COMMENTLEXUZ"><img src="/image/favicon.gif" /> LexUZ sharhi</div><div name="-4895447" id="-4895447">Mazkur buyruq Oʻzbekiston Respublikasi sogʻliqni saqlash vazirining 2020-yil 8-iyundagi 122-sonli “Kam uchraydigan kasalliklarni davolash uchun moʻljallangan Orfan dori vositalari roʻyxatini tasdiqlash toʻgʻrisida”gi <a href="/mact/-4890616?ONDATE=30.06.2020 00#-4890744">buyrugʻiga </a>(roʻyxat raqami 3258, 30.06.2020-y.) asosan oʻz kuchini yoʻqotgan.</div></div><div class="ACT_TEXT"><div name="-4368092" id="-4368092">Oʻzbekiston Respublikasining “Dori vositalari va farmatsevtika faoliyati toʻgʻrisida”gi Qonuniga muvofiq buyuraman:</div></div><div class="ACT_TEXT"><div name="-4368093" id="-4368093">1. Kam uchraydigan kasalliklarni davolash uchun moʻljallangan Orfan dori vositalari roʻyxati <a href="/mact/-4367869#-4368100">ilovaga </a>muvofiq tasdiqlansin.</div></div><div class="ACT_TEXT"><div name="-4368094" id="-4368094">2. Oʻzbekiston Respublikasi sogʻliqni saqlash vazirining 2016-yil 23-iyundagi 57-son “Kam uchraydigan kasalliklarni davolash uchun moʻljallangan Orfan dori vositalari roʻyxatini tasdiqlash toʻgʻrisida”gi <a href="/mact/-2995684">buyrugʻi </a>(roʻyxat raqami 2805, 2016-yil 1-iyul) (Oʻzbekiston Respublikasi qonun hujjatlari toʻplami, 2016-y., 26-son, 325-modda) oʻz kuchini yoʻqotgan deb topilsin.</div></div><div class="ACT_TEXT"><div name="-4368095" id="-4368095">3. Mazkur buyruq rasmiy eʼlon qilingan kundan eʼtiboran kuchga kiradi.</div></div><div class="SIGNATURE"><div name="-4368096" id="-4368096">Vazir A. ShADMANOV</div></div><div class="ACT_ESSENTIAL_ELEMENTS"><div name="-4368097" id="-4368097">Toshkent sh.,</div></div><div class="ACT_ESSENTIAL_ELEMENTS"><div name="-4368098" id="-4368098">2019-yil 22-may,</div></div><div class="ACT_ESSENTIAL_ELEMENTS_NUM"><div name="-4368099" id="-4368099">76-son</div></div><div class="BY_DEFAULT"><div name="-4368100" id="-4368100"></div></div><div class="APPL_BANNER_LANDSCAPE_TITLE"><div name="-4368101" id="-4368101">Oʻzbekiston Respublikasi sogʻliqni saqlash vazirining 2019-yil 22-maydagi 76-son <a href="/mact/-4367869">buyrugʻiga </a><br />ILOVA </div></div><div class="ACT_TITLE_APPL"><div name="-4368102" id="-4368102">Kam uchraydigan kasalliklarni davolash uchun moʻljallangan Orfan dori vositalari</div></div><div class="ACT_FORM"><div name="-4368103" id="-4368103">ROʻYXATI</div></div><div class="BY_DEFAULT"><div name="-4368104" id="-4368104"></div></div><div class="BY_DEFAULT"><div name="-4368105" id="-4368105"><table style="BACKGROUND: white; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><b><span style="FONT-SIZE: 12pt; COLOR: black">T/r</span></b></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal" align="center"><b><span style="FONT-SIZE: 12pt; COLOR: black">Dori vositasining xalqaro patentlanmagan nomi</span></b></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><b><span style="FONT-SIZE: 12pt; COLOR: black">Kasalliklarning xalqaro tasnifi boʻyicha kasallik guruhi</span></b></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><b><span style="FONT-SIZE: 12pt; COLOR: black">Kasallikning nomi (uning sinonimi)</span></b></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><b><span style="FONT-SIZE: 12pt; COLOR: black">Kasalliklarning xalqaro tasnifi (KXT-10) boʻyicha kodi</span></b></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">1.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Dapson </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="3">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Lepra</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="3">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Lepra (Ganzen kasalligi)</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%" rowspan="3">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">A-30</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">2</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Tigazon</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">3.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Klofazimin</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">4.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Glyukantim </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="5">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Leyshmanioz</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="5">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Teri leyshmaniozi, visseral leyshmanioz</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%" rowspan="5">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">B-55</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">5.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Metatsiklin</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">6.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Rondomitsin</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">7</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Doksilan</span></p></td></tr>
<tr style="HEIGHT: 2.5pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">8.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Xingamin </span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">9.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%" rowspan="2">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Kafast</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Angiokeratoma</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Fabri kasalligi (angiokeratoma)</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">D-18</span></p></td></tr>
<tr style="HEIGHT: 15.85pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 15.85pt" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">Tugʻma diafragmal churra</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">Lokal sklerodermiya</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 15.85pt" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">Tugʻma diafragmal churra</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">Lokal sklerodermiya</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 15.85pt" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">Q 79.0-</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">L 94-</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">10.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Kuriozin</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Pensigoid</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Bullyoz epidermoliz</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Q-81</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">11.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Argosulfan</span></p></td></tr>
<tr style="HEIGHT: 2.5pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">12.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Paraaminobenzoy kislota</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" valign="top" width="22%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">-boshka epidermal qalinlashish</span></p>
<p style="LINE-HEIGHT: normal"></p>
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">Ovqat hazm qilish tizimi va qorin boʻshligʻiga tegishli boshka simptom va belgilar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" valign="top" width="22%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">-boshqa epidermal qalinlashish</span></p>
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line"><br />Ovqat hazm qilish tizimi va qorin boʻshligʻiga tegishli boshka simptom va belgilar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line"><br /><br />L 85</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">R 19-</span></p>
<p style="LINE-HEIGHT: normal" align="center"></p></td></tr>
<tr style="HEIGHT: 2.5pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">13.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Penitsilamin</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Vilsona-Konavalova sindromi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Vilsona-Konavalova sindromi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">E 83.0</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">14.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Gansiklovir </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">tsitomegaliovirus kasallik </span></p>
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Kriptokokkoz</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">tsitomegaliovirus kasallik Kriptokokkoz</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">V 25-</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">V 45-</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">15.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Raltegravir</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="28">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Odamning immunitet tanqisligi virusi (OIV) tomonidan chaqirilgan kasallik, Odamning immunitet tanqisligi virusi (OIV) rezistent shtamlari</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="28">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Odamning immunitet tanqisligi virusi (OIV) tomonidan chaqirilgan kasallik, Odamning i�munitet tanqisligi virusi (OIV) rezistent shtamlari</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%" rowspan="28">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">B 20-B 24</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">16.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Dalutegravir</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">17.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Darunovir</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">18.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Atazanavir</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">19.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Zidovudin </span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">20.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Lamivudin </span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">21.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Abakavir </span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">22.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Tenofovir </span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">23.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Emtritsitabin </span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">24.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Rilpivirin</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">25.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Efavirenz</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">26.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Nevirapin</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">27.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Etraverin</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">28.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Ritonavir</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">29.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Elvitegravir</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">30.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Maravirok</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">31.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Zidovudin + Lamivudin</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">32.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Abakavir + Lamivudin</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">33.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Emtritsitabin + Tenofovir</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">34.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Lamivudin + Tenofovir</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">35.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Efavirenz + Emtritsitabin + Tenofovir </span></p></td></tr>
<tr style="HEIGHT: 2.5pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">36.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Efavirenz + Lamivudin + Tenofovir </span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">37.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Rilpivirin + Emtritsitabin + Tenofovir </span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">38.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Lopinavir + Ritonavir</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">39.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Darunavir+ Kombisistat</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">40.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Atazanavir+ Kombisistat</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">41.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Atazanavir+ Ritonavir</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">42.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Elvitegravir + Kobisistat + Emtritsitabin + Tenofovir</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">43.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Koartem</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Bezgak</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Bezgak</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">V 52</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">44.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Takrolimus</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Buyrak koʻchirib oʻtkazilgandan keyingi holat</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Buyrak koʻchirib oʻtkazilgandan keyingi holat</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">Z 94 </span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">45.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Mikofenolat natriya</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Buyrak koʻchirib oʻtkazilgandan keyingi holat</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Buyrak koʻchirib oʻtkazilgandan keyingi holat</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">Z 94 </span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">46.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Baziliksimab</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Buyrak koʻchirib oʻtkazilgandan keyingi holat</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Buyrak koʻchirib oʻtkazilgandan keyingi holat</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">Z 94 </span></p></td></tr>
<tr style="HEIGHT: 3pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 3pt" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">47.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 3pt" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Primaxin</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 3pt" width="22%" rowspan="10">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Pl. Malariae,<br /><br /></span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Pl. Falciparum</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 3pt" width="22%" rowspan="10">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Bezgak</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 3pt" width="20%" rowspan="10">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">V 53</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">48.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Xinidin</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">49.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Xloroxin</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">50.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Xinin</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">51.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Atremetr</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">52.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Artesunat</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">53.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Lariam</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">54.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Fansidar</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">55.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Ambizom</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">56.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Pentostam</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">57.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Liposomalli Amfoteritsin V </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Zamburugʻ </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Zamburugʻ </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">V 55</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">58.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Antilimfotsitar globulin A</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Aplastik anemiya</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Aplastik anemiya</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">D 61</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">59.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Paromomitsin sulfat</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Leyshmanioz</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Leyshmanioz</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">B 55</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">60.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Interferon beta</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Bolalarda uchraydigan burun-halqum xavfli oʻsmalari</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Burun-halqum xavfli oʻsmasi (nazofarengial karsinoma)</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">S 11</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">61.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Melfalan</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Bolalarda uchraydigan koʻz va uning yondosh apparati, toʻr parda xavfli oʻsmalari</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Toʻr parda xavfli oʻsmasi (retinoblastoma)</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">C 69.2</span></p></td></tr>
<tr style="HEIGHT: 2.5pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">62.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Mitotan</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Buyrak usti bezi xavfli oʻsmasi </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Buyrak usti bezi poʻstloq qismi xavfli oʻsmasi </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">C 74.0</span></p></td></tr>
<tr style="HEIGHT: 2.5pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">63.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Lomustin</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="22%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Bosh miya xavfli oʻsmalari, xavfli limfomalari</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="22%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Bosh miya xavfli oʻsmalari, xavfli limfomalari</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="20%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">S 71</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">64.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Nimustin</span></p></td></tr>
<tr style="HEIGHT: 2.5pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">65.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Adsetris</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Limfoprolifera iv kasalliklar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Xodjkin limfomasi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">S 80</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">66.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Syetuksimab</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Bosh-boʻyin xavfli oʻsmalari </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Bosh-boʻyin (ogʻiz, burun, halqum boʻshliqlari) xavfli oʻsmalari</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">C 00-C 14</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">67.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Prospidiya xlorid</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Sarkoma Kaposhi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Sarkoma Kaposhi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">S 46</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">68.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Alitretinoin </span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">69.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Azatsitidin</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="9">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Miyeloid, qon yaratuvchi va ularga yaqin boʻlgan toʻqimalar xavfli oʻsmalari, Limfoid, qon ishlab chiqaruvchi va ularga yaqin boʻlgan toʻqimalar xavfli oʻsmalari, Limfoid leykozi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="9">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Limfoid leykozi (limfoleykoz), Miyelom kasalligi, surunkali miyeloleykoz, </span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">oʻtkir leykozlar, </span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">xoj sochlik leykoz</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%" rowspan="9">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">C 88, S 90, C 91. S 92, S 92.1,</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">S 92.4, S 93, C 94, S 95, S 96,S 91.4</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">70.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Asparaginaza</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">71.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Bendamustin </span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">72.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Bortezomib</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">73.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Idarubitsin</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">74.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Imatinib</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">75.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Kladribin</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">76.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Mofetila mikofenolat</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">77.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">PEGAsparaginaza</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">78.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Tretinoin</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Limfoid leykozi (limfoleykoz), qon ishlab chiqaruvchi va ularga yaqin boʻlgan toʻqimalar xavfli oʻsmalari</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Oʻtkir limfoblast leykozi, </span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">oʻtkir leykozlar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">S 92.4</span></p></td></tr>
<tr style="HEIGHT: 27.15pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 27.15pt" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">79.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 27.15pt" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Deferoksamin</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 27.15pt" width="22%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Gemolitik kam qonliklar, Qon va qon yaratuvchi organlar kasalliklari va immun mexanizmini jalb etuvchi ayrim buzilishlar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 27.15pt" width="22%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Alfa-talassemiya, beta-talassemiya, delta-beta-talassemiya, Aplastik kamqonliklar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 27.15pt" width="20%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">D 56, D 61</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">80.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Deferaziroks</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">81.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Antitimotsitar globulin</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="3">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Qon va qon yaratuvchi organlar kasalliklari va immun mexanizmini jalb etuvchi ayrim buzilishlar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="3">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Aplastik kamqonliklar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%" rowspan="3">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">D 61</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">82.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Siklosporin</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">83.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Antitimotsitar immunoglobulin (ATG)</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">84.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Tirozinkinaza ingibitorlari</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="6">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Miyeloid, qon ishlab chiqaruvchi va ularga yaqin boʻlgan toʻqimalar xavfli oʻsmalari </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="6">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Surunkali miyeloleykoz</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%" rowspan="6">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">C 92.1</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">85.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Interferon alfa</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">86.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Tasigna </span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">87.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Spraysel</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">88.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Vilate</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">89.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Odam leykotsitar interferoni</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">90.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Metilprednizolon</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Qon va qon ishlab chiqaruvchi organlar kasalliklari va immun mexanizmini jalb etuvchi ayrim buzilishlar </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Idiopatik trombotsitopenik purpura </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">D 69.3</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">91.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Imiglyutseraza</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">I tipdagi Goshe kasalligi </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">D 80, E 75.2</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">92.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Lenalidomid</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Miyeloid, qon ishlab chiqaruvchi va ularga yaqin boʻlgan toʻqimalar xavfli oʻsmalari</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Miyelodisplastik sindrom</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">D 46</span></p></td></tr>
<tr style="HEIGHT: 3pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 3pt" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">93.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 3pt" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Mitoksantron</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 3pt" width="22%" rowspan="3">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Limfoid, qon ishlab chiqaruvchi va ularga yaqin boʻlgan toʻqimalar xavfli oʻsmalari</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 3pt" width="22%" rowspan="3">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Oʻtkir leykozlar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 3pt" width="20%" rowspan="3">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">S 88.0-S 92.4-92.0</span></p></td></tr>
<tr style="HEIGHT: 2.5pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">94.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Azotsidin</span></p></td></tr>
<tr style="HEIGHT: 2.5pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">95.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Palivizumab</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">96.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Salofalk</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Kron kasalligi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Kron kasalligi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">K 50</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">97.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Triyentin</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Vilson-Konovalov kasalligi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Vilson-Konovalov kasalligi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">E 83.0</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">98.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Tetratiomolibdat</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Vilson kasalligi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Vilson kasalligi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">E 83.0</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">99.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Mitoksantrin</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">100.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Bromitob</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="3">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Mukovissidoz</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="3">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Mukovissidoz </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%" rowspan="3">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">E 84</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">101.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Tobidornazar alfa</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">102.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Dornaza-alfa</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">103.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Tobramitsin (ingalatsion shakl)</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Boshka koʻrinishlarga ega kistozli fibroz</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Fibroz kistozining majmuaviy shakli (mukovissidoz)</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">E 84,8 </span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">104.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%" rowspan="2">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt">Okrelizumab</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Tarqoq skleroz, Bolalarda uchraydigan tarqoq skleroz</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Tarqoq skleroz, Sil sklerozining kompleksi </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">G 35</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">(SEGA)</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">105.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Bozentan</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Birlamchi oʻpka gipertenziyasi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Idiopatik oʻpka arterial gipotenziyasi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">I 27.0</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">106.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Odam normal immunoglobulini</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Purpura va boshqa gemorragik holatlar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Idiopatik trombotsitopenik purpura </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">D 69</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">107.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Azatioprin</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Toʻqimalar birlashishining tizimli zararlanishi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Vegenera Granulomatozining mikroskopik poliangiti</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">M 35</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">108.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Metotreksat</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">109.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Ibandron kislotasi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Yakunlanmagan osteogenez</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Yakunlanmagan osteogenez</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">S 88-S 90</span></p></td></tr>
<tr style="HEIGHT: 8.3pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 8.3pt" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">110.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 8.3pt" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Siklosporin A</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 8.3pt" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Alport sindromi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 8.3pt" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Alport sindromi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 8.3pt" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Q 87.8</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">111.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Trenaksan</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Gemorragik sindromlar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Gemafiliya A, V, Villebrand kasalligi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">D 66, D 67, D 68</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">112.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Aminoglutyetimid</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="4">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Gipofiz giperfunksiyasi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Kushing sindromi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%" rowspan="4">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">E 22</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">E 24 </span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">113.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Lanrenotid</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="3">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Akromegaliya Kushing sindromi</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">114.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Kabergolin</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">115.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Parlodel</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">116.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Rastan</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="3">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Boshqa endokrin kasalliklar </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="3">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Pradera-Villi sindromi,</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Nunan Shereshevskiy-Ternera sindromi </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Q 87.1</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">117.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Norditropin</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Q 96</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">118.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Kortizon</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">-</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">119.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Glatiramer atsetat</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Tarqoq skleroz</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Tarqoq skleroz</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">G 35</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">120.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">II VII VIII IX va X qon koagulatsiya omili</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Gemofiliya A, V, Villebrand kasalligi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Gemofiliya A, V, Villebrand kasalligi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">D 66, D 67, D 68</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">121.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Sitarabin</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Mileloid leykoz</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Mileloid leykoz</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">S 91-S 92</span></p></td></tr>
<tr style="HEIGHT: 20.6pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 20.6pt" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">122.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 20.6pt" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Gidrokortizon</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 20.6pt" width="22%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Adrenogenital buzilishlar </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 20.6pt" width="22%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Fermentlar tanqisligi bilan bogʻliq boʻlgan tugʻma adrenogenital buzilishlar</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 20.6pt" width="20%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">E 25.0,</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">E 27.1</span></p></td></tr>
<tr style="HEIGHT: 2.5pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">123.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 2.5pt" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Kortineff</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">124.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Kalsitriol</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Surunkali buyrak yetishmovchiligi, Vitamin D rezistent raxit (fosfat diabet, buyrak raxiti)</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Surunkali buyrak yetishmovchiligi, Vitamin D rezistent raxit (fosfat diabet, buyrak raxiti)</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">N</span><span style="FONT-SIZE: 12pt; COLOR: black"> 18,</span></p>
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">E 83.31</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">125.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">Totsilizumab (Aktemra)</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="22%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">Sistem boshlanishli yoshlar artriti</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">Yuvenil idiopatik artrit tizimli varianti </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%" rowspan="2">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">M 08.2- </span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">126.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">Siklosporin</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">127.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">Glekaprevir (100mg)+Pirbrentasvir (40mg)</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" valign="top" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">Virusli gepatit</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">Surunkali virusli gepatit S </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">B 18.2</span></p></td></tr>
<tr>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt">128.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="32%">
<p style="LINE-HEIGHT: normal"><span style="FONT-SIZE: 12pt; COLOR: black">Laronidaza (Aldurazim)</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Mukopolisaxaridoz</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">I tipdagi Mukopolisaxaridoz </span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">E 76</span></p></td></tr>
<tr style="HEIGHT: 15.2pt">
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: windowtext 1pt solid; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 15.2pt" width="3%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">129.</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 15.2pt" width="32%">
<p style="LINE-HEIGHT: normal"></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 15.2pt" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Birlamchi immuntaqisligi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 15.2pt" valign="top" width="22%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; COLOR: black">Birlamchi immuntaqisligi</span></p></td>
<td style="BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; PADDING-LEFT: 2.85pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #-ece9d8; PADDING-TOP: 0cm; BORDER-BOTTOM: windowtext 1pt solid; HEIGHT: 15.2pt" valign="top" width="20%">
<p style="LINE-HEIGHT: normal" align="center"><span style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">D80.0-D84.0 </span></p></td></tr></tbody></table></div></div><div class="PUBLICATION_ORIGIN"><label id="s1089"></label><div name="-4368090" id="-4368090">(Qonun hujjatlari maʼlumotlari milliy bazasi, 08.06.2019-y., 10/19/3164/3255-son)</div></div></div>
        </div>
    </div>
    <div style="display: none;">
<!-- START WWW.UZ TOP-RATING -->
<SCRIPT language="javascript" type="text/javascript">
		<!--
		top_js = "1.0"; top_r = "id=4079&r=" + escape(document.referrer) + "&pg=" + escape(window.location.href); document.cookie = "smart_top=1; path=/"; top_r += "&c=" + (document.cookie ? "Y" : "N")
		//-->
</SCRIPT>
<SCRIPT language="javascript1.1" type="text/javascript">
<!--
		top_js = "1.1"; top_r += "&j=" + (navigator.javaEnabled() ? "Y" : "N")
//-->
</SCRIPT>
<SCRIPT language="javascript1.2" type="text/javascript">
<!--
		top_js = "1.2"; top_r += "&wh=" + screen.width + 'x' + screen.height + "&px=" + (((navigator.appName.substring(0, 3) == "Mic")) ? screen.colorDepth : screen.pixelDepth)
//-->
</SCRIPT>
<SCRIPT language="javascript1.3" type="text/javascript">
<!--
		top_js = "1.3";
//-->
</SCRIPT>
<SCRIPT language="JavaScript" type="text/javascript">
		<!--
		top_rat = "&col=0C57A6&t=ffffff&p=DD7900"; top_r += "&js=" + top_js + ""; document.write('<a href="https://www.uz/rus/toprating/cmd/stat/id/4079" target="_blank"><img src="https://www.uz/plugins/top_rating/count/cnt.png?' + top_r + top_rat + '" width=88 height=31 border=0 alt="Топ рейтинг www.uz"></a>')//-->
</SCRIPT>
<NOSCRIPT>
		<A href="https://www.uz/rus/toprating/cmd/stat/id/4079" target="_blank">
				<img height="31" src="https://www.uz/plugins/top_rating/count/nojs_cnt.png?id=4079&pg=http%3A//lex.uz&col=0C57A6&t=ffffff&p=DD7900" width="88" border="0" alt="Топ рейтинг www.uz">
		</A>
</NOSCRIPT>
<!-- FINISH WWW.UZ TOP-RATING --></div>
</body>
</html>
<script>
    function scrollText(hash) {
        location.href = "#" + hash;
        if (window.location.hash) {
            var y = $(window.location.hash).offset().top - 3;
            window.scrollTo(0, y);
        }
    }
</script>
